Computed Tomography–Based Imaging Algorithms for Patient Selection in Acute Ischemic Stroke

Published:March 23, 2021DOI:https://doi.org/10.1016/j.nic.2020.12.002

      Keywords

      To read this article in full you will need to make a payment
      Purchase one-time access
      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
      Content published before 2002 is available via pay-per-view purchase only.
      Subscribe to Neuroimaging Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Virani S.S.
        • Alonso A.
        • Benjamin E.J.
        • et al.
        Heart disease and stroke statistics-2020 update: a report from the American heart association.
        Circulation. 2020; 141: e139-e596
        • National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
        Tissue plasminogen activator for acute ischemic stroke.
        N Engl J Med. 1995; 333: 1581-1587
        • Hacke W.
        • Kaste M.
        • Bluhmki E.
        • et al.
        Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.
        N Engl J Med. 2008; 359: 1317-1329
        • Ma H.
        • Campbell B.C.V.
        • Parsons M.W.
        • et al.
        Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke.
        N Engl J Med. 2019; 380: 1795-1803
        • Broderick J.P.
        • Palesch Y.Y.
        • Demchuk A.M.
        • et al.
        Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.
        N Engl J Med. 2013; 368: 893-903
        • Kidwell C.S.
        • Jahan R.
        • Gornbein J.
        • et al.
        A trial of imaging selection and endovascular treatment for ischemic stroke.
        N Engl J Med. 2013; 368: 914-923
        • Ciccone A.
        • Valvassori L.
        • Nichelatti M.
        • et al.
        Endovascular treatment for acute ischemic stroke.
        N Engl J Med. 2013; 368: 904-913
        • Albers G.W.
        • Marks M.P.
        • Kemp S.
        • et al.
        Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.
        N Engl J Med. 2018; 378: 708-718
        • Berkhemer O.A.
        • Fransen P.S.
        • Beumer D.
        • et al.
        A randomized trial of intraarterial treatment for acute ischemic stroke.
        N Engl J Med. 2015; 372: 11-20
        • Bracard S.
        • Ducrocq X.
        • Mas J.L.
        • et al.
        Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial.
        Lancet Neurol. 2016; 15: 1138-1147
        • Campbell B.C.
        • Mitchell P.J.
        • Kleinig T.J.
        • et al.
        Endovascular therapy for ischemic stroke with perfusion-imaging selection.
        N Engl J Med. 2015; 372: 1009-1018
        • Goyal M.
        • Demchuk A.M.
        • Menon B.K.
        • et al.
        Randomized assessment of rapid endovascular treatment of ischemic stroke.
        N Engl J Med. 2015; 372: 1019-1030
        • Jovin T.G.
        • Chamorro A.
        • Cobo E.
        • et al.
        Thrombectomy within 8 hours after symptom onset in ischemic stroke.
        N Engl J Med. 2015; 372: 2296-2306
        • Nogueira R.G.
        • Jadhav A.P.
        • Haussen D.C.
        • et al.
        Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct.
        N Engl J Med. 2018; 378: 11-21
        • Saver J.L.
        • Goyal M.
        • Bonafe A.
        • et al.
        Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.
        N Engl J Med. 2015; 372: 2285-2295
        • Lev M.H.
        • Farkas J.
        • Gemmete J.J.
        • et al.
        Acute stroke: improved nonenhanced CT detection--benefits of soft-copy interpretation by using variable window width and center level settings.
        Radiology. 1999; 213: 150-155
        • Lodder J.
        CT-detected hemorrhagic infarction; relation with the size of the infarct, and the presence of midline shift.
        Acta Neurol Scand. 1984; 70: 329-335
        • Castellanos M.
        • Leira R.
        • Serena J.
        • et al.
        Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke.
        Stroke. 2003; 34: 40-46
        • Tanne D.
        • Kasner S.E.
        • Demchuk A.M.
        • et al.
        Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.
        Circulation. 2002; 105: 1679-1685
        • Cucchiara B.
        • Kasner S.E.
        • Tanne D.
        • et al.
        Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials.
        Stroke. 2009; 40: 3067-3072
        • Logallo N.
        • Novotny V.
        • Assmus J.
        • et al.
        Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
        Lancet Neurol. 2017; 16: 781-788
        • Touma L.
        • Filion K.B.
        • Sterling L.H.
        • et al.
        Stent retrievers for the treatment of acute ischemic stroke: a systematic review and meta-analysis of randomized clinical trials.
        JAMA Neurol. 2016; 73: 275-281
        • Barber P.A.
        • Demchuk A.M.
        • Zhang J.
        • et al.
        Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS study group. alberta stroke programme early CT score.
        Lancet. 2000; 355: 1670-1674
        • Mak H.K.
        • Yau K.K.
        • Khong P.L.
        • et al.
        Hypodensity of >1/3 middle cerebral artery territory versus Alberta Stroke Programme Early CT Score (ASPECTS): comparison of two methods of quantitative evaluation of early CT changes in hyperacute ischemic stroke in the community setting.
        Stroke. 2003; 34: 1194-1196
        • Vagal A.
        • Aviv R.
        • Sucharew H.
        • et al.
        Collateral clock is more important than time clock for tissue fate.
        Stroke. 2018; 49: 2102-2107
        • Nambiar V.
        • Sohn S.I.
        • Almekhlafi M.A.
        • et al.
        CTA collateral status and response to recanalization in patients with acute ischemic stroke.
        AJNR Am J Neuroradiol. 2014; 35: 884-890
        • Souza L.C.
        • Yoo A.J.
        • Chaudhry Z.A.
        • et al.
        Malignant CTA collateral profile is highly specific for large admission DWI infarct core and poor outcome in acute stroke.
        AJNR Am J Neuroradiol. 2012; 33: 1331-1336
        • Menon B.K.
        • d'Esterre C.D.
        • Qazi E.M.
        • et al.
        Multiphase CT angiography: a new tool for the imaging triage of patients with acute ischemic stroke.
        Radiology. 2015; 275: 510-520
        • Wheeler H.M.
        • Mlynash M.
        • Inoue M.
        • et al.
        The growth rate of early DWI lesions is highly variable and associated with penumbral salvage and clinical outcomes following endovascular reperfusion.
        Int J Stroke. 2015; 10: 723-729
        • Astrup J.
        • Siesjö B.K.
        • Symon L.
        Thresholds in cerebral ischemia - the ischemic penumbra.
        Stroke. 1981; 12: 723-725
        • Albers G.W.
        Late window paradox.
        Stroke. 2018; 49: 768-771
        • Kamalian S.
        • Kamalian S.
        • Konstas A.A.
        • et al.
        CT perfusion mean transit time maps optimally distinguish benign oligemia from true "at-risk" ischemic penumbra, but thresholds vary by postprocessing technique.
        AJNR Am J Neuroradiol. 2012; 33: 545-549
        • Christensen S.
        • Mlynash M.
        • Kemp S.
        • et al.
        Persistent target mismatch profile >24 hours after stroke onset in DEFUSE 3.
        Stroke. 2019; 50: 754-757
      1. A randomized controlled trial of TNK-tPA versus standard of care for minor ischemic stroke with proven occlusion (TEMPO-2). ClinicalTrials.gov Identifier: NCT02398656.
        (Available at:) (Accessed July 16, 2020)
      2. Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE) Trial. ACTRN12613000243718.
        (Available at:) (Accessed July 16, 2020)
      3. Tenecteplase in stroke patients between 4.5 and 24 Hours (TIMELESS). ClinicalTrials.gov Identifier: NCT03785678.
        (Available at:) (Accessed July 16, 2020)
        • Gautheron V.
        • Xie Y.
        • Tisserand M.
        • et al.
        Outcome after reperfusion therapies in patients with large baseline diffusion-weighted imaging stroke lesions: a THRACE Trial (Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke) subgroup analysis.
        Stroke. 2018; 49: 750-753
        • Sarraj A.
        • Hassan A.E.
        • Savitz S.
        • et al.
        Outcomes of endovascular thrombectomy vs medical management alone in patients with large ischemic cores: a secondary analysis of the optimizing patient's selection for endovascular treatment in acute ischemic stroke (SELECT) study.
        JAMA Neurol. 2019; 76: 1147-1156
        • Campbell B.C.V.
        • Majoie C.
        • Albers G.W.
        • et al.
        Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data.
        Lancet Neurol. 2019; 18: 46-55
        • Román L.S.
        • Menon B.K.
        • Blasco J.
        • et al.
        Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data.
        Lancet Neurol. 2018; 17: 895-904
        • Yoo A.J.
        • Verduzco L.A.
        • Schaefer P.W.
        • et al.
        MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization.
        Stroke. 2009; 40: 2046-2054
        • Lansberg M.G.
        • Straka M.
        • Kemp S.
        • et al.
        MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study.
        Lancet Neurol. 2012; 11: 860-867
        • Bhuva P.
        • Yoo A.J.
        • Jadhav A.P.
        • et al.
        Noncontrast computed tomography Alberta Stroke Program Early CT Score may modify intra-arterial treatment effect in DAWN.
        Stroke. 2019; 50: 2404-2412
        • Bendszus M.
        • Bonekamp S.
        • Berge E.
        • et al.
        A randomized controlled trial to test efficacy and safety of thrombectomy in stroke with extended lesion and extended time window.
        Int J Stroke. 2019; 14: 87-93
      4. SELECT 2: a randomized controlled trial to optimize patient's selection for endovascular treatment in acute ischemic stroke. ClinicalTrials.gov Identifier: NCT03876457..
        (Available at:) (Accessed July 16, 2020)
      5. Large stroke therapy evaluation (LASTE). ClinicalTrials.gov Identifier: NCT03811769.
        (Available at:) (Accessed July 16, 2020)
      6. The TESLA Trial: thrombectomy for emergent salvage of large anterior circulation ischemic stroke (TESLA). ClinicalTrials.gov Identifier: NCT03805308.
        (Available at:) (Accessed July 16, 2020)
        • Haussen D.C.
        • Lima F.O.
        • Bouslama M.
        • et al.
        Thrombectomy versus medical management for large vessel occlusion strokes with minimal symptoms: an analysis from STOPStroke and GESTOR cohorts.
        J Neurointerv Surg. 2018; 10: 325-329
        • Wolman D.N.
        • Marcellus D.G.
        • Lansberg M.G.
        • et al.
        Endovascular versus medical therapy for large-vessel anterior occlusive stroke presenting with mild symptoms.
        Int J Stroke. 2020; 15: 324-331
        • Sarraj A.
        • Hassan A.
        • Savitz S.I.
        • et al.
        Endovascular thrombectomy for mild strokes: how low should we go?.
        Stroke. 2018; 49: 2398-2405
        • Haussen D.C.
        • Bouslama M.
        • Grossberg J.A.
        • et al.
        Too good to intervene? Thrombectomy for large vessel occlusion strokes with minimal symptoms: an intention-to-treat analysis.
        J Neurointerv Surg. 2017; 9: 917-921
        • Nagel S.
        • Bouslama M.
        • Krause L.U.
        • et al.
        Mechanical thrombectomy in patients with milder strokes and large vessel occlusions.
        Stroke. 2018; 49: 2391-2397
        • Heldner M.R.
        • Jung S.
        • Zubler C.
        • et al.
        Outcome of patients with occlusions of the internal carotid artery or the main stem of the middle cerebral artery with NIHSS score of less than 5: comparison between thrombolysed and non-thrombolysed patients.
        J Neurol Neurosurg Psychiatry. 2015; 86: 755-760
        • Cerejo R.
        • Cheng-Ching E.
        • Hui F.
        • et al.
        Treatment of patients with mild acute ischemic stroke and associated large vessel occlusion.
        J Clin Neurosci. 2016; 30: 60-64
        • Goyal M.
        • Menon B.K.
        • van Zwam W.H.
        • et al.
        Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.
        Lancet. 2016; 387: 1723-1731
      7. Endovascular therapy for low NIHSS Ischemic Strokes (ENDOLOW). ClinicalTrials.gov Identifier: NCT04167527.
        (Available at:) (Accessed July 16, 2020)
        • Powers W.J.
        • Rabinstein A.A.
        • Ackerson T.
        • et al.
        Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association.
        Stroke. 2019; 50: e344-e418
        • Leslie-Mazwi T.M.
        • Hamilton S.
        • Mlynash M.
        • et al.
        DEFUSE 3 non-DAWN patients.
        Stroke. 2019; 50: 618-625